Kensington Investment Counsel’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Kensington Investment Counsel's AMGN Position: Q2 2026 in Review
Kensington Investment Counsel reduced its Amgen (AMGN) stake by 6.6% in Q2 2026, selling an estimated $397K and leaving 16,454 shares worth $5.96M. The position accounts for 2.59% of the portfolio, ranked #12.
Kensington Investment Counsel first reported a position in AMGN in Q4 2020 and has held it in 22 quarters since. The position peaked at $6.2M in Q1 2026. 3,153 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Kensington Investment Counsel held 16,454 shares of Amgen worth $5.96M as of Q2 2026.
- Kensington Investment Counsel sold 1,161 Amgen shares in Q2 2026, an estimated $397K.
- Amgen made up 2.59% of Kensington Investment Counsel's portfolio in Q2 2026, its #12 holding.
- Kensington Investment Counsel first reported a position in Amgen in Q4 2020 and has held it in 22 quarters since.
- Kensington Investment Counsel's Amgen position peaked at $6.2M in Q1 2026.
- 3,153 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Kensington Investment Counsel's 13F filing for Q2 2026, filed 14 Aug 2026.